İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2016

Risk factors for infection with colistin-resistant gram-negative microorganisms: a multicenter study

Dergi

Annals of Saudi Medicine

ISSN 0256-4947

YÖKSİS OpenAlex Açık erişim · diamond SJR Q3 JCR Q4 Atıf 25 Yüzdelik 82.7% FWCI 1.73
Yıl
2016
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Annals of Saudi Medicine
  • Katalog eşleşmesi (ISSN) Annals of Saudi Medicine
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

BACKGROUND: Knowing risk factors for colistin resistance is important since colistin is the only remaining choice for the treatment of infections caused by multi-drug resistant microorganisms. OBJECTIVE: Evaluate risk factors associated with infection by colistin-resistant microorganisms. DESIGN: Retrospective study. SETTING: Tertiary healthcare centers. PATIENTS AND METHODS: An e-mail including the title and purpose of the study was sent to 1500 infec.tious disease specialists via a scientific and social web portal named "infeksiyon dunyasi (infection world)". Demographic and clinical data was requested from respondents. MAIN OUTCOME MEASURE(S): Colistin-resistance. RESULTS: Eighteen infectious disease specialists from twelve tertiary care centers responded to the invitation data was collected on 165 patients, 56 cases (39.9%) and 109 (66.0%) age- and sex-matched controls. The colistin-resistant microorganisms isolated from cases were 29 Acinetobacter baumannii (51.8%), 18 Pseudomonas aeruginosa (32.1%) and 9 Klebsiella spp. Colistin, carbapenem, and quinolone use in the last three months were risk factors for colistin resistance in the univariate analysis. Previous quinolone use in the last three months (P=.003; RR:3.2; 95% Ci:1.5-6,7) and previous colistin use in the last three months (P=.001; RR: 3.6; 95% CI: 1.63-7.99) were significant risk factors in the multivariate analysis. CONCLUSION: Clinicians should limit the use of quinolones and remain aware of the possibility of resistance developing during colistin use. LIMITATIONS: The lack of a heteroresistance analysis on the isolates. no data on use of a loading dose or the use of colistin in combination.

Konular

  • Antibiotic Resistance in Bacteria
  • Pneumonia and Respiratory Infections
  • Antibiotic Use and Resistance

Birincil konu Antibiotic Resistance in Bacteria

Yazarlar

  1. Gul R. YILMAZ
  2. MURAT DİZBAY
  3. TÜMER GÜVEN
  4. HÜSNÜ PULLUKÇU
  5. MELTEM TAŞBAKAN
  6. HATİCE RAHMET GÜNER
  7. YASEMİN ÇAĞ
  8. FATMA BOZKURT İSTANBUL ATLAS ÜNİVERSİTESİ
  9. FATMA YILMAZ KARADAĞ